Neurocrine Biosciences Ownership | Who Owns Neurocrine Biosciences?
Neurocrine Biosciences Ownership Summary
Neurocrine Biosciences is owned by 98.95% institutional investors, 1.06% insiders. Blackrock is the largest institutional shareholder, holding 14.22% of NBIX shares. Dodge & Cox Stock I is the top mutual fund, with 4.01% of its assets in Neurocrine Biosciences shares.
NBIX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Neurocrine Biosciences | 98.95% | 1.06% | - |
| Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
| Industry | Specialty & Generic Drug Manufacturers Stocks | 43.51% | 11.55% | 44.95% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock | 14.19M | 14.22% | $1.95B |
| Blackrock funding, inc. /de | 12.95M | 13.09% | $1.63B |
| Vanguard group | 10.12M | 10.01% | $1.38B |
| Dodge & cox | 5.57M | 5.62% | $699.69M |
| State street | 4.61M | 4.62% | $634.43M |
| Renaissance | 2.49M | 2.46% | $339.80M |
| Aqr capital management | 1.90M | 1.88% | $258.93M |
| Geode capital management | 1.88M | 1.85% | $255.52M |
| Bellevue group | 1.82M | 1.84% | $228.76M |
| Morgan stanley | 1.54M | 1.55% | $212.68M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Sarissa capital management lp | 303.15K | 24.68% | $38.10M |
| Superstring capital management lp | 40.61K | 6.04% | $5.10M |
| Eagle health investments lp | 155.00K | 5.19% | $21.16M |
| Bellevue group | 1.82M | 5.04% | $228.76M |
| Braidwell lp | 1.16M | 4.99% | $145.85M |
| Sio capital management | 100.72K | 4.84% | $12.66M |
| Healthinvest partners ab | 88.39K | 4.75% | $11.11M |
| Birchview capital, lp | 30.94K | 3.86% | $3.89M |
| Silverarc capital management | 162.97K | 3.78% | $20.48M |
| Saturn v capital management | 58.18K | 2.96% | $7.31M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Rtw investments, lp | 1.06M | 1.90% | 1.06M |
| Los angeles capital management | 744.65K | 0.35% | 740.84K |
| Wellington management group llp | 1.46M | 0.04% | 739.20K |
| Thrivent financial for lutherans | 737.77K | 0.20% | 711.97K |
| State street | 4.61M | 0.03% | 618.40K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock funding, inc. /de | 12.95M | 0.03% | -1.73M |
| Dsm capital partners | - | - | -932.60K |
| Point72 asset management | - | - | -837.43K |
| Jupiter asset management | - | - | -582.79K |
| Morgan stanley | 1.54M | 0.02% | -520.77K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Rtw investments, lp | 1.06M | 1.90% | 1.06M | $133.49M |
| Adage capital partners gp | 341.58K | 0.07% | 341.58K | $42.93M |
| Norges bank | 325.30K | 0.01% | 325.30K | $44.40M |
| Zurich insurance group ltd/fi | 211.91K | 0.21% | 211.91K | $26.64M |
| Susquehanna portfolio strategies | 184.03K | 0.51% | 184.03K | $23.13M |
Sold Out
| Holder | Change |
|---|---|
| Rothschild investment | -3.00 |
| Rosenberg matthew hamilton | -4.00 |
| Dt investment partners | -5.00 |
| Private wealth asset management | -6.00 |
| Financial synergies wealth advisors | -9.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 588 | 0.17% | 97,956,548 | 4.05% | 98 | 1.11% | 302 | 20.32% | 215 | -15.02% |
| Mar 31, 2025 | 585 | -3.94% | 94,105,380 | -0.29% | 94 | 1.07% | 246 | -24.31% | 257 | 22.38% |
| Dec 31, 2024 | 555 | -5.77% | 87,755,246 | -5.34% | 86 | 1.03% | 288 | -3.36% | 196 | -2.97% |
| Sep 30, 2024 | 585 | -3.31% | 92,570,293 | -1.20% | 91 | 1.06% | 297 | -9.17% | 200 | 6.38% |
| Jun 30, 2024 | 596 | -0.83% | 93,638,169 | 0.75% | 93 | 1.08% | 321 | 1.90% | 187 | -10.10% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Dodge & Cox Stock I | 3.96M | 4.01% | - |
| iShares Core S&P Mid-Cap ETF | 3.22M | 3.25% | -5.78K |
| Vanguard US Total Market Shares ETF | 3.20M | 3.21% | 2.53K |
| Vanguard Total Stock Mkt Idx Inv | 3.12M | 3.14% | -71.50K |
| Vanguard Small Cap Index | 2.40M | 2.42% | -15.57K |
| BB Biotech AG Ord | 1.82M | 1.80% | -40.00K |
| Vanguard Small Cap Growth Index Inv | 1.35M | 1.36% | -3.15K |
| Vanguard Windsor Investor Shares | 1.13M | 1.14% | -2.80K |
| JPM US Mid Cap Growth-Composite | 1.12M | 1.13% | 543.28K |
| JPMorgan Mid Cap Growth I | 1.12M | 1.12% | 84.25K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Aug 07, 2025 | GORMAN KEVIN CHARLES | - | Sell | $13.44M |
| Jul 10, 2025 | Delaet Ingrid | Chief Regulatory Officer | Sell | $61.70K |
| Jul 09, 2025 | Onyia Jude | Chief Scientific Officer | Sell | $7.80M |
| Jul 02, 2025 | Onyia Jude | Chief Scientific Officer | Sell | $2.65M |
| May 27, 2025 | GORMAN KEVIN CHARLES | - | Sell | $1.16M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q3 | - | 4 |
| 2025 Q2 | - | 2 |
| 2025 Q1 | - | 45 |
| 2024 Q4 | - | 4 |
| 2024 Q3 | - | 18 |
NBIX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools